SpaceX IPO at 94x Sales? Here's Why I'm Sitting This One Out
SpaceX IPO at 94x Sales? Here's Why I'm Sitting This One Out
Straight to it: I'm not buying this IPO
SpaceX is going public on June 12 at roughly $135 per share, aiming for a $1.75 to $2 trillion market cap right out of the gate. It launches rockets, it's led by Elon Musk, and it comes wrapped in a Mars story. And I'm still stepping back from it.
My reasoning isn't emotional. It comes down to one line of math.
The core: what a 94x price-to-sales ratio is telling you
The first number I look at on any valuation is the price-to-sales ratio — how much the market is paying for every dollar of revenue a company actually brings in.
SpaceX has about $18 billion in revenue. Set the target market cap at $1.75-$2 trillion and the ratio lands around 94x.
Here's the frame I use:
| Category | P/S ratio |
|---|---|
| Healthy | Under 2x |
| Expensive | Above 4x |
| SpaceX target | ~94x |
If I call anything over 4x expensive, then 94x is in another universe. It means a flawless future is already priced in. Starlink scaling explosively, the Mars business becoming real, launch costs falling for years — all of it baked into the price before day one.
What it means: a great company isn't a great investment
I'm not saying SpaceX is a bad company. It might be one of the most impressive companies of our era. But a great company and a great entry price are two completely different things.
On IPO day — especially for a hyped name — retail investors often end up holding the most expensive shares. Institutions and early backers got in far lower, and the launch-day excitement becomes the stage where they take profits.
That's why, instead of buying the stock directly, I lean toward indirect exposure through ETFs that give me a measured slice of names like this while diversification keeps the risk in check.
The risk and the counterargument
There's a fair pushback: "P/S doesn't matter for some companies." Amazon looked expensive on every traditional metric early on and still beat the market.
True. But that's survivorship — the rare names that made it. To bet on 94x, nearly everything has to go perfectly. I don't have enough conviction to put my capital behind those odds. I'll watch until the price comes back to something rational, or until revenue grows into the valuation.
Investing isn't a game of finding great companies. It's a game of buying great companies at good prices.
More in this Category
Meta Drops 10% on Earnings: 28% Revenue Growth Against a 91% Free Cash Flow Collapse
Meta Drops 10% on Earnings: 28% Revenue Growth Against a 91% Free Cash Flow Collapse
Meta posted $60.8 billion in revenue, up 28%, but EPS came in at $6.18 against a $7.15 consensus, and free cash flow fell from over $8.5 billion a year ago to $784 million. My ten-year model puts the midpoint fair value at $925.
Oracle at a 52-Week Low: A $638 Billion Backlog Against Negative Free Cash Flow
Oracle at a 52-Week Low: A $638 Billion Backlog Against Negative Free Cash Flow
Oracle secured a $638 billion backlog (up 363%) and a Department of Defense contract, but free cash flow is negative $23 billion, S&P cut its rating to BBB, and the company is raising $40 billion. My ten-year model puts the midpoint at $200.
I Split My 65-Stock Watchlist Into Three Tiers: Why 9%, 12%, and 15% Are Completely Different Decisions
I Split My 65-Stock Watchlist Into Three Tiers: Why 9%, 12%, and 15% Are Completely Different Decisions
Of the 65 names on my watchlist, 37 have moved into my calculation range: 14 project 9-10% annually, 13 project 11-15%, and 10 project above 15%. What separates the tiers isn't business quality — it's today's price.
Next Posts
The AI Memory Gold Rush: The Real Money Is in the Picks and Shovels — A 5-Layer Supply Map
The AI Memory Gold Rush: The Real Money Is in the Picks and Shovels — A 5-Layer Supply Map
In the HBM memory boom, the steadiest money isn't in the makers but in the suppliers underneath — the tools, inspectors, testers, bonders, and materials. Here are 10 names across a 5-layer stack that get paid whether SK Hynix, Samsung, or Micron wins.
Why HBM Is Eating the World — Micron's $1 Trillion and the Memory Supercycle
Why HBM Is Eating the World — Micron's $1 Trillion and the Memory Supercycle
AI is consuming memory faster than the world can make it: HBM prices roughly doubled in a single quarter, makers are sold out into next year, and Micron just crossed $1 trillion. Here's why this supercycle is structurally different from past memory cycles.
Memory ETFs: DRAM vs HBMX — Not Which to Buy, but What Each One Holds
Memory ETFs: DRAM vs HBMX — Not Which to Buy, but What Each One Holds
Roundhill's DRAM ETF holds only the makers — Micron, SK Hynix, Samsung — while the new HBMX reaches down into equipment, packaging, and materials too. The point isn't which is better; it's that the two cover completely different parts of the same machine.
Previous Posts
The Quiet Tax on Cash: Why Financial Repression May Be Coming Back
The Quiet Tax on Cash: Why Financial Repression May Be Coming Back
From 1946 to 1974 the US held rates below inflation and cut public debt from 106% to 24% of GDP — with cash holders footing the bill. Now that debt is back near 100% of GDP, a former Fed chair has warned the same playbook is on the table.
The 3 Forms of Financial Repression Hiding in Your Portfolio Right Now
The 3 Forms of Financial Repression Hiding in Your Portfolio Right Now
Rate suppression, the pension tilt, and tolerance drift. With a 0.45% savings account yielding −2.4% real against 3.8% inflation and target-date funds auto-buying long Treasuries, financial repression is already live inside your accounts.
The 3-Move Defense Against the Quiet Tax: Real Assets, a TIPS Ladder, and Dividend Compounding
The 3-Move Defense Against the Quiet Tax: Real Assets, a TIPS Ladder, and Dividend Compounding
Same $100,000, but one saver ends a decade at $77,700 real and the other at $122,000. Here's the three-move defense — a real-asset anchor, a TIPS ladder, and dividend compounding — laid out with the numbers behind each.